Search Results
Feb 12, 2026, 17:55 ET Greenberg Traurig Attorneys, Practices Recognized in 2026 Chambers Global Guide
Mark S. Selinger (Capital Markets, Israel) is recognized as Foreign Expertise Based Abroad in USA Spotlight.
More news about: Greenberg Traurig, LLP
Feb 12, 2026, 17:54 ET Engrain Files Federal Copyright Infringement Lawsuit Against Beans.ai to Protect Its Intellectual Property and 15 Years of Mapping Innovation
georeferencing anomalies, and specific software artifacts—corroborating Engrain's belief that the defendants intentionally and deliberately copied 1000s of Engrain's copyrighted works rather than creating original content."True innovation doesn't happen through shortcuts," said Brent Steiner, CEO
More news about: Engrain
Feb 12, 2026, 17:45 ET Avances de la demanda antimonopolio de USAP Texas: los demandantes amplían la demanda colectiva en todo el estado y a los ASC
McAvoy de Shinder Cantor Lerner LLP; Kimberly A. Justice, Robert J. Wozniak y Samantha M. Gupta de Freed Kanner London & Millen LLP; y Justin S. Nematzadeh de Nematzadeh PLLC.ACERCA DE GIBBS & BRUNS LLPGibbs & Bruns LLP es una boutique de litigios dedicada
More news about: Gibbs & Bruns LLP
Feb 12, 2026, 17:30 ET AGNICO EAGLE PROVIDES AN UPDATE ON 2025 EXPLORATION RESULTS AND 2026 EXPLORATION PLANS - YEAR OVER YEAR MINERAL RESERVES INCREASE 2% TO 55.4 MOZ; INDICATED MINERAL RESOURCES INCREASE 10% TO 47.1 MOZ AND INFERRED MINERAL RESOURCES INCREASE 15% TO 41.8 MOZ
($ 000s)($ 000s)(000s m)
More news about: Agnico Eagle Mines Limited
Feb 12, 2026, 17:27 ET /C O R R E C T I O N -- CARFAX/
recognized as a top workplace by The Washington Post. Shop, Buy, Service, Sell – Show me the CARFAX®.S&P Global Mobility is a division of S&P Global (NYSE: SPGI). S&P Global is the world's foremost provider of credit ratings, benchmarks, analytics and workflow solutions in the global
More news about: CARFAX
Feb 12, 2026, 17:00 ET Hormel Foods Names Will Bonifant Group Vice President and Chief Supply Chain Officer
BLACK LABEL®, COLUMBUS®, JENNIE-O® and more than 30 other beloved brands. The company is a member of the S&P 500 Index and the S&P 500 Dividend Aristocrats, was named one of the best companies to work for by U.S. News & World Report, one of America's most responsible
More news about: Hormel Foods Corporation
Feb 12, 2026, 17:00 ET PTC Therapeutics Provides Regulatory Update on Translarna™
Duchenne is a rare and fatal genetic disorder that results in progressive muscle weakness from early childhood and leads to premature death in the mid-20s due to heart and respiratory failure. It is a progressive muscle disorder caused by the lack of functional dystrophin protein. Dystrophin is critical
More news about: PTC Therapeutics, Inc.
Feb 12, 2026, 17:00 ET Cineverse Announces Proposed Public Offering of Class A Common Stock
The Benchmark Company, LLC is acting as the sole underwriter for the proposed offering. A shelf registration statement on Form S-3 (File No. 333-273098) relating to the shares was previously filed with the Securities and Exchange Commission (the "SEC") and became effective
More news about: Cineverse Corp.
Feb 12, 2026, 17:00 ET AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE
($ 000s)($ 000s)(000s m)
More news about: Agnico Eagle Mines Limited
Feb 12, 2026, 17:00 ET BLADEX ANNOUNCES NET PROFITS OF $56.0 MILLION OR $1.50 PER SHARE IN 4Q25 AND $226.9 MILLION OR $6.11 PER SHARE IN 2025
14.9% of total assets as of December 31, 2025, mostly consisting of deposits placed with the Federal Reserve Bank of New York (91%).The Bank´s Tier 1 Basel III Capital and Regulatory Capital Adequacy Ratios resulted in 17.4% and 15.5% at the end of 4Q25, respectively, both well above internal
More news about: Bladex
Feb 12, 2026, 16:54 ET Reopening the doorway to a Shanghai cultural touchstone
cultural heritage.First appearing in the 1870s, shikumen buildings, named after their signature stone-framed doors, carry a traditional architectural style unique to Shanghai, featuring a combination of Chinese and Western elements.By the 1920s and '30s, two-thirds of Shanghai's populace lived
More news about: China Daily
Feb 12, 2026, 16:30 ET Cooper Standard Reports Strong Fourth Quarter Cash Flow Despite Industry Disruption; Continued Margin Expansion and Positive Cash Flow Highlight Full Year 2025 Results
management's estimates and expectations as of the date it is published. Current guidance as presented in this press release considers January 2026 S&P Global (IHS Markit) production forecasts for relevant light vehicle platforms and models, customers' planned production schedules and other internal
More news about: Cooper Standard
Feb 12, 2026, 16:24 ET Lucid dévoile The Seven Suite : une immersion dans le son, l'espace et le mouvement électrique
https://spgroup.box.com/s/ig3c1zs1kp74n4s52pbzaqtwjlqio1z0À propos de Lucid Group Lucid (NASDAQ : LCID) est une entreprise technologique basée dans la Silicon
More news about: Lucid Group
Feb 12, 2026, 16:17 ET The India Fund, Inc. (IFN) Announces Name Change
Limited.Aberdeen Investments is one of the world's largest asset management firms with extensive experience in managing closed-end funds dating back to the 1980s. As of December 31, 2025, Aberdeen Investments had approximately $525 billion in assets under management.
More news about: The India Fund, Inc.
Feb 12, 2026, 16:15 ET Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
feasibility, or utility of the Hemopurifier®; the Company's ability to initiate, enroll, conduct, and complete its clinical trials, including in Australia s; the timing, scope, design, and potential outcomes or interpretation of such studies; the Company's ability to manufacture the Hemopurifier in sufficient
More news about: Aethlon Medical, Inc.
Feb 12, 2026, 16:05 ET FLOWERS FOODS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
(000's omitted)
More news about: Flowers Foods, Inc.
Feb 12, 2026, 16:05 ET BioMarin Announces Closing of Private Offering of Senior Notes
"qualified institutional buyers" as defined in Rule 144A under the Securities Act or (2) non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes are subject to restrictions on transferability and resale and may not be transferred or resold except in compliance
More news about: BioMarin Pharmaceutical Inc.
Feb 12, 2026, 16:05 ET Federal Realty Investment Trust Reports Fourth Quarter and Full Year 2025 Results
Realty has increased its quarterly dividends to its shareholders for 58 consecutive years, the longest record in the REIT industry. The company is an S&P 500 index member and its shares are traded on the NYSE under the symbol FRT. For additional information about Federal Realty and its properties, visit
More news about: Federal Realty Investment Trust
Feb 12, 2026, 16:04 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in F5, Inc. of Class Action Lawsuit and Upcoming Deadlines - FFIV
the Company's BIG-IP product development and engineering management platforms were compromised, including the BIG-IP source code.On this news, F5's stock price fell $47.82 per share, or 13.93%, over the following two trading sessions, to close at $295.35 per share on October 16, 2025.Then,
More news about: Pomerantz LLP
Feb 12, 2026, 16:02 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107's overall regulatory and commercial prospects were overstated; and (v) as a result, Defendants' public statements were materially false and misleading
More news about: Pomerantz LLP
Feb 12, 2026, 16:00 ET BMO Announces Upcoming Splits of Three Series of its Exchange Traded Notes (NYSE Arca: BULZ, SHNY and SPYU)
to track general stock market performance.The S&P 500® Index is a product of S&P Dow Jones Indices LLC ("SPDJI"), and has been licensed for use by BMO. Standard & Poor's®, S&P®, S&P 500®, US 500 and The 500 are registered trademarks
More news about: BMO Financial Group
Feb 12, 2026, 15:36 ET National Genealogical Society Welcomes Major General (Retired) Garrett Yee as Honorary Chairman of Veteran Bounty Land Records Capital Campaign
Feb. 10, 2026 /PRNewswire/ -- The National Genealogical Society (NGS) is proud to announce the appointment of Major General (Retired) Garrett S. Yee as Honorary Chairman of the Veteran Bounty Land Records (VBLR) capital fundraising campaign, a landmark initiative to preserve and digitize historic
More news about: National Genealogical Society
Feb 12, 2026, 15:32 ET The Howard and Georgeanna Jones Foundation for Reproductive Medicine announces new $75,000 Bridge Funding Award
MedicineThe Howard and Georgeanna Jones Foundation for Reproductive Medicine was founded by IVF pioneers Dr. Howard W. Jones, Jr. and Dr. Georgeanna S. Jones who established the first in vitro fertilization program in the United States, the Jones Institute for Reproductive Medicine. The Jones institute
More news about: The Howard and Georgeanna Jones Foundation for Reproductive Medicine
Feb 12, 2026, 15:30 ET LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE
cell depletion identified in muscle-specific kinase myasthenia gravis. JCI Insight. 2017;2(17):e94263.Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7-16. Nowak R, Benatar M, Ciafaloni E, et al. A phase 3 trial
More news about: Amgen
Feb 12, 2026, 15:15 ET La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada
cell depletion identified in muscle-specific kinase myasthenia gravis. JCI Insight. 2017;2(17):e94263.Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7-16. Nowak R, Benatar M, Ciafaloni E, et al. A phase 3 trial
More news about: Amgen